References
1. Mockenhaupt, M., Epidemiology of cutaneous adverse drug reactions. Chem Immunol Allergy, 2012. 97 : p. 1-17.
2. Chaby, G., et al., Incidence of and mortality from epidermal necrolysis (Stevens-Johnson syndrome/toxic epidermal necrolysis) in France during 2003-16: a four-source capture-recapture estimate. Br J Dermatol, 2020. 182 (3): p. 618-624.
3. Schmidt, V., et al., Intravenous immunoglobulins, cyclosporine, and best supportive care in epidermal necrolysis: Diverse effects on systemic inflammation. Allergy, 2022.